| Product NDC: | 55045-3259 | 
| Proprietary Name: | TERCONAZOLE | 
| Non Proprietary Name: | terconazole | 
| Active Ingredient(s): | 8 mg/g & nbsp; terconazole | 
| Administration Route(s): | VAGINAL | 
| Dosage Form(s): | CREAM | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 55045-3259 | 
| Labeler Name: | Dispensing Solutions, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA019964 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20040401 | 
| Package NDC: | 55045-3259-3 | 
| Package Description: | 20 g in 1 TUBE, WITH APPLICATOR (55045-3259-3) | 
| NDC Code | 55045-3259-3 | 
| Proprietary Name | TERCONAZOLE | 
| Package Description | 20 g in 1 TUBE, WITH APPLICATOR (55045-3259-3) | 
| Product NDC | 55045-3259 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | terconazole | 
| Dosage Form Name | CREAM | 
| Route Name | VAGINAL | 
| Start Marketing Date | 20040401 | 
| Marketing Category Name | NDA | 
| Labeler Name | Dispensing Solutions, Inc. | 
| Substance Name | TERCONAZOLE | 
| Strength Number | 8 | 
| Strength Unit | mg/g | 
| Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |